Dr. Garett Rhule, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,741 | 101 | 99.7% |
| Education | $5.40 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $356.11 | 29 | $0 (2020) |
| Novo Nordisk Inc | $282.13 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $176.01 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $139.91 | 8 | $0 (2019) |
| Amgen Inc. | $138.53 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $134.11 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $112.80 | 18 | $0 (2017) |
| Medtronic, Inc. | $88.68 | 2 | $0 (2023) |
| Lilly USA, LLC | $80.06 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $51.64 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.54 | 9 | Novo Nordisk Inc ($94.40) |
| 2023 | $57.04 | 1 | Medtronic, Inc. ($57.04) |
| 2022 | $139.18 | 4 | Novo Nordisk Inc ($69.06) |
| 2020 | $48.96 | 3 | PFIZER INC. ($29.63) |
| 2019 | $170.21 | 7 | Amgen Inc. ($96.54) |
| 2018 | $398.20 | 20 | Novo Nordisk Inc ($118.67) |
| 2017 | $735.60 | 58 | PFIZER INC. ($171.31) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes Care | ||||||
| 04/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 06/30/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $57.04 | General |
| Category: Durable Pump | ||||||
| 10/12/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 07/01/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.79 | General |
| Category: Medical Device | ||||||
| 03/28/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $69.06 | General |
| Category: Diabetes | ||||||
| 03/28/2022 | Itamar Medical Inc | WatchPAT (Device) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: Sleep Apnea testing | ||||||
| 03/12/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Endocrinology | ||||||
| 01/29/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/27/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/14/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Cardiology | ||||||
| 03/05/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $70.30 | General |
| Category: Bone Health | ||||||
| 02/05/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 407 | 1,593 | $128,988 | $35,119 |
| 2022 | 13 | 475 | 654 | $166,439 | $48,250 |
| 2021 | 5 | 280 | 433 | $109,394 | $31,417 |
| 2020 | 6 | 251 | 364 | $92,388 | $21,815 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 240 | $69,600 | $19,639 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 119 | $23,681 | $6,717 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $11,596 | $2,592 | 22.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $1,650 | $1,504 | 91.1% |
| 77067 | Screening mammography | Office | 2023 | 14 | 14 | $5,355 | $1,303 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,991 | $1,135 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 19 | $2,660 | $752.19 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $960.00 | $695.75 | 72.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 13 | 13 | $1,436 | $315.12 | 21.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 14 | $3,616 | $224.52 | 6.2% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 12 | 1,062 | $1,062 | $122.34 | 11.5% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 27 | 27 | $3,381 | $119.52 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 276 | $77,832 | $23,723 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 146 | $28,178 | $8,443 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $13,826 | $3,203 | 23.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $8,088 | $3,140 | 38.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $11,434 | $2,786 | 24.4% |
| 77067 | Screening mammography | Office | 2022 | 23 | 23 | $8,550 | $2,200 | 25.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 23 | $1,725 | $1,576 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $1,315 | $979.39 | 74.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $4,298 | $936.60 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $2,677 | $534.81 | 20.0% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 18 | 18 | $1,945 | $437.92 | 22.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 18 | $4,344 | $216.14 | 5.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 17 | 17 | $2,227 | $72.65 | 3.3% |
About Dr. Garett Rhule, MD
Dr. Garett Rhule, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Williston, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972791259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Garett Rhule, MD has received a total of $1,747 in payments from pharmaceutical and medical device companies, with $197.54 received in 2024. These payments were reported across 102 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,741).
As a Medicare-enrolled provider, Rhule has provided services to 1,413 Medicare beneficiaries, totaling 3,044 services with total Medicare billing of $136,600. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Williston, ND
- Active Since 10/11/2007
- Last Updated 12/26/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1972791259
Products in Payments
- ELIQUIS (Drug) $287.75
- FARXIGA (Drug) $153.31
- ENTRESTO (Drug) $139.91
- XARELTO (Drug) $123.35
- Tresiba (Drug) $113.58
- Prolia (Biological) $97.51
- Rybelsus (Drug) $86.70
- Ozempic (Drug) $81.85
- MINIMED 780G (Device) $57.04
- MOUNJARO (Drug) $56.31
- Myrbetriq (Drug) $51.64
- VIAGRA (Drug) $42.59
- LYRICA (Drug) $36.74
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $31.64
- BREO (Drug) $31.30
- VRAYLAR (Drug) $28.38
- Repatha (Biological) $26.24
- Trintellix (Drug) $25.94
- WatchPAT (Device) $24.69
- FREESTYLE LIBRE 3 (Device) $24.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Williston
Amy Taggart
Student in an Organized Health Care Education/Training Program — Payments: $106.42
Catherine Koubek
Student in an Organized Health Care Education/Training Program — Payments: $64.11
Dr. Hooria Manzoor, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18.71
Shannon Burns, Pa-C, Atc, PA-C, ATC
Student in an Organized Health Care Education/Training Program
Dr. Pirthvi Raj Giyanwani, Md, MD
Student in an Organized Health Care Education/Training Program
Ashley Richardson
Student in an Organized Health Care Education/Training Program